← SynDRA
ENTOSPLETINIB
SynDRA canonical compound SYN0038013 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | SYK |
|---|
| Mechanism of action | Syk inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- SYK INHIBITOR
- Tyrosine-protein kinase SYK inhibitor
- SYK MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- BTK
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- FLT3
- HDAC6
- JAK2
- KCNH2
- KDR
- NTRK1
- PTK6
- RET
- ROS1
Cross-references
Synonyms
- CG9
- CPD 68
- ENTOSPLETINIB (GS-9973)
- ENTOSPLETINIB DIMESYLATE
- GS-9973
- GS9973
- SYK INHIBITOR GS-9973
- GS 9973
- Entospletinib (GS-9973)
- gs9973
- UNII-6I3O3W6O3B
- 6-(1H-Indazol-6-yl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine
- 6I3O3W6O3B
- CHEMBL3265032
- C23H21N7O
- 6-(1H-Indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine
- Entospletinib [INN]
- Entospletinib [USAN:INN]
- 4puz
- 6-(1h-Indazol-6-Yl)-N-[4-(Morpholin-4-Yl)phenyl]imidazo[1,2-A]pyrazin-8-Amine
- SCHEMBL2483776
- GTPL7889
- MolPort-035-395-879
- HMS3653D13
- EX-A1120
- BCP09582
- AOB87385
- entospletinibum
- RefChem:590865
- DTXCID201747475
- MFCD28099806
- GS9973Entospletinib
- GS9973Entospletinib?
- GS-9973; Entospletinib
- Entospletinib (USAN/INN)
- ENTOSPLETINIB [USAN]
- ENTOSPLETINIB [WHO-DD]
- orb1301072
- SCHEMBL29355138
Look up ENTOSPLETINIB in the interactive SynDRA portal →